Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.) is a listed company. Filings by its managers are published through SEDI. Over the twelve months to 18 October 2026, the company's managers filed 14 filings, from 3 insiders.
On the market, 1 insider bought (1 purchase) while 1 insider sold (1 sale). No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 senior executive.
The most recent open-market purchase was published on 29 June 2026, 110 days ago. The median gap between a trade and its publication by SEDI is 7 days. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (2,121 companies, median 11 filings), a count of 14 filings is above the norm. Looking back to 2026, when coverage begins, insiders filed 1 purchase and 1 sale.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
FY ended December 2025 · cache
14 of 14 declarations
Rocket Doctor AI Inc. is a company focused on developing artificial intelligence solutions for the healthcare sector. Formerly known as Treatment.com AI Inc., it aims to enhance patient care through technology.
Insider filings
Over the last 90 days, 6 filings published on 6 October 2026: no open-market purchase or sale filed by an insider. 6 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 13 October 2026 (UTC)